Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús A García

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Journal of Psychopharmacology (Oxford, England)|June 16, 2016
Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in miceBenjamin Keller, Jesús A García-Sevilla
Neurochemistry International|March 27, 2017
Effects of I<sub>2</sub>-imidazoline receptor (IR) alkylating BU99006 in the mouse brain: Upregulation of nischarin/I<sub>1</sub>-IR and μ-opioid receptor proteins and modulation of associated signalling pathwaysBenjamin Keller, Jesús A García-Sevilla
Journal of Affective Disorders|November 13, 2016
Dysregulation of IRAS/nischarin and other potential I<sub>1</sub>-imidazoline receptors in major depression postmortem brain: Downregulation of basal contents by antidepressant drug treatmentsBenjamin Keller, Jesús A García-Sevilla
Journal of Psychopharmacology (Oxford, England)|June 4, 2015
Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugsBenjamin Keller, Jesús A García-Sevilla
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 3, 2011
Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disordersSusana Esteban, Jesús A García-Sevilla
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2015
Regulation of hippocampal Fas receptor and death-inducing signaling complex after kainic acid treatment in miceBenjamin Keller, Jesús A García-Sevilla
Sensors (Basel, Switzerland)|November 17, 2020
A Low-Cost Calibration Method for Low-Cost MEMS Accelerometers Based on 3D PrintingJesús A García, Evangelina Lara, Leocundo Aguilar
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 19, 2015
The neuroplastic index p-FADD/FADD and phosphoprotein PEA-15, interacting at GABAA receptor, are upregulated in brain cortex during midazolam-induced hypnosis in miceMaría Álvaro-Bartolomé, Jesús A García-Sevilla
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 6, 2004
Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brainDavid Moranta, Susana Esteban, Jesús A García-Sevilla
Neuroscience Letters|September 27, 2005
Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivoDavid Moranta, Susana Esteban, Jesús A García-Sevilla
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Journal of Psychopharmacology (Oxford, England)|June 16, 2016
Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in miceBenjamin Keller, Jesús A García-Sevilla
Neurochemistry International|March 27, 2017
Effects of I<sub>2</sub>-imidazoline receptor (IR) alkylating BU99006 in the mouse brain: Upregulation of nischarin/I<sub>1</sub>-IR and μ-opioid receptor proteins and modulation of associated signalling pathwaysBenjamin Keller, Jesús A García-Sevilla
Journal of Affective Disorders|November 13, 2016
Dysregulation of IRAS/nischarin and other potential I<sub>1</sub>-imidazoline receptors in major depression postmortem brain: Downregulation of basal contents by antidepressant drug treatmentsBenjamin Keller, Jesús A García-Sevilla
Journal of Psychopharmacology (Oxford, England)|June 4, 2015
Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugsBenjamin Keller, Jesús A García-Sevilla
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 3, 2011
Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disordersSusana Esteban, Jesús A García-Sevilla
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2015
Regulation of hippocampal Fas receptor and death-inducing signaling complex after kainic acid treatment in miceBenjamin Keller, Jesús A García-Sevilla
Sensors (Basel, Switzerland)|November 17, 2020
A Low-Cost Calibration Method for Low-Cost MEMS Accelerometers Based on 3D PrintingJesús A García, Evangelina Lara, Leocundo Aguilar
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 19, 2015
The neuroplastic index p-FADD/FADD and phosphoprotein PEA-15, interacting at GABAA receptor, are upregulated in brain cortex during midazolam-induced hypnosis in miceMaría Álvaro-Bartolomé, Jesús A García-Sevilla
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 6, 2004
Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brainDavid Moranta, Susana Esteban, Jesús A García-Sevilla
Neuroscience Letters|September 27, 2005
Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivoDavid Moranta, Susana Esteban, Jesús A García-Sevilla
Pageof 9